Project Number 1R01AG061848-01 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for COMBINATION ANTI-AMYLOID THERAPY FOR PRECLINICAL ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 8. Late-stage Clinical Drug Development (Phase II/III and III Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator AISEN, PAUL S Principal Investigator First Name PAUL Principal Investigator Last Name AISEN Awardee Organization UNIVERSITY OF SOUTHERN CALIFORNIA Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-513: Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) FY Overall Cost $9,021,816 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MCLINDEN, KRISTINA Special Initiative Alzheimer's Clinical Trials Consortium (ACTC)
